Newcastle University
Toggle Main Menu
Toggle Search
Home
Browse
Latest
Policies
About
Home
Browse
Latest
Policies
About
ePrints
Browse by author
Browsing publications by
Dr Urszula McClurg.
Newcastle Authors
Title
Year
Full text
Dr Suzanne Madgwick
Dr Urszula McClurg
Towards inclusive and sustainable scientific meetings
2023
Dr Lisa Prendergast
Dr Urszula McClurg
Dr Rolando Berlinguer Palmini
Sarah Marshall
Inmaculada Hernandez Lopez
et al.
Resolution of R-loops by INO80 promotes DNA replication and maintains cancer cell proliferation and viability
2020
Dr Urszula McClurg
Svitlana Korolchuk
Dr Stuart McCracken
Professor Rakesh Heer
Laura Wilson
et al.
Human
ex vivo
prostate tissue model system identifies ING3 as an oncoprotein
2018
Dr Urszula McClurg
Dr Mahsa Azizyan
Dr Sirintra Nakjang
Dr Stuart McCracken
Professor Craig Robson
et al.
Molecular mechanism of the TP53-MDM2-AR-AKT signalling network regulation by USP12
2018
Dr Urszula McClurg
Dr Mahsa Azizyan
Dr Sirintra Nakjang
Professor Craig Robson
The novel anti-androgen candidate galeterone targets deubiquitinating enzymes, USP12 and USP46, to control prostate cancer growth and survival
2018
Dr Urszula McClurg
Dr David Cork
Dr Steven Darby
Claudia Ryan-Munden
Dr Sirintra Nakjang
et al.
Identification of a novel K311 ubiquitination site critical for androgen receptor transcriptional activity
2017
Dr Urszula McClurg
Dr Olivier Binda
ING3 promotes prostate cancer growth by activating the androgen receptor.
2017
Dr Jennifer Munkley
Dr Urszula McClurg
Karen Livermore
Dr Ingrid Ehrmann
Professor Craig Robson
et al.
The cancer-associated cell migration protein TSPAN1 is under control of androgens and its upregulation increases prostate cancer cell migration
2017
Dr Urszula McClurg
Dr Sirintra Nakjang
Dr Stuart McCracken
Professor Craig Robson
A novel anti-androgen candidate galeterone acts by targeting USP12, a deubiquitinating enzyme that controls prostate cancer growth and survival
2016
Dr Urszula McClurg
Dr Olivier Binda
Professor Craig Robson
Mechanism of Histone H3K4me3 Recognition by the Plant Homeodomain of Inhibitor of Growth 3
2016
Dr Ian Logan
Dr Urszula McClurg
Dr Dominic Jones
Daniel O'Neill
Dr Fadhel Shaheen
et al.
Nutlin-3 inhibits androgen receptor-driven c-FLIP expression, resulting in apoptosis of prostate cancer cells
2016
Dr Urszula McClurg
Professor Craig Robson
Deubiquitinating enzymes as oncotargets.
2015
Dr Urszula McClurg
Epithelial cell ADAM17 activation by
Helicobacter pylori:
role of ADAM17
C
-terminus and Threonine-735 phosphorylation
2015
Dr Jennifer Munkley
Karen Livermore
Dr Urszula McClurg
Professor Craig Robson
Dr Prabhakar Rajan
et al.
The PI3K regulatory subunit gene
PIK3R1
is under direct control of androgens and repressed in prostate cancer cells
2015
Dr Urszula McClurg
Victoria Harle
Dr Scott Walker
Dr Kelly Coffey
Dr Luke Gaughan
et al.
Ubiquitin-specific protease 12 interacting partners Uaf-1 and WDR20 are potential therapeutic targets in prostate cancer
2015
Dr Urszula McClurg
Victoria Harle
Dr Luke Gaughan
Professor Craig Robson
Deubiquitinating enzyme Usp12 regulates the interaction between the androgen receptor and the Akt pathway
2014
Dr Urszula McClurg
Two plasmid-encoded genes of enteropathogenic
Escherichia coli
strain K798 promote invasion and survival within HEp-2 cells
2014
Dr Urszula McClurg
Victoria Harle
Dr Kelly Coffey
Dr Steven Darby
Hollie Ramsey
et al.
Usp12 a novel AR co-regulator and PCa biomarker?
2014
Dr Urszula McClurg
Victoria Harle
Dr Kelly Coffey
Dr Steven Darby
Hollie Ramsey
et al.
Deubiquitinating Enzyme Usp12 Is a Novel Co-activator of the Androgen Receptor
2013